Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-20-006863
Filing Date
2020-06-22
Accepted
2020-06-22 10:01:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberMYGN-202013g.htm SC 13G 60107
2 JOINT FILING AGREEMENT MYGN13g2020ex1.htm EX-1 4964
  Complete submission text file 0001654954-20-006863.txt   66661
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-48577 | Film No.: 20977431
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

EIN.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G